Skip to main content
Top
Published in: Obesity Surgery 4/2020

Open Access 01-04-2020 | Bariatric Surgery | Original Contributions

Bariatric Surgery in Cirrhotic Patients: Is It Safe?

Authors: Hafsa Younus, Amit Sharma, Rosa Miquel, Alberto Quaglia, Subba Rao Kanchustambam, Kirstin A Carswell, Ameet G. Patel

Published in: Obesity Surgery | Issue 4/2020

Login to get access

Abstract

Introduction

Ten percent of cirrhotic patients are known to have a high risk of postoperative complications. Ninety percent of bariatric patients suffer from non-alcoholic fatty liver disease (NAFLD), and 50% of them may develop non-alcoholic steatohepatitis (NASH) which can progress to cirrhosis. The aim of this study was to assess whether the presence of cirrhosis at the time of bariatric surgery is associated with an increased rate and severity of short- and long-term cirrhotic complications.

Methods

A cohort of 110 bariatric patients, between May 2003 and February 2018, who had undergone liver biopsy at the time of bariatric surgery were reassessed for histological outcome and divided into two groups based on the presence (C, n = 26) or absence (NC, n = 84) of cirrhosis. The NC group consisted of NASH (n = 49), NAFLD (n = 24) and non-NAFLD (n = 11) liver histology. Medical notes were retrospectively assessed for patient characteristics, development of 30-day postoperative complications, severity of complications (Clavien-Dindo (CD) classification) and length of stay. The C group was further assessed for long-term cirrhosis-related outcomes.

Results

The C group was older (52 years vs 43 years) and had lower BMI (46 kg/m2 vs 52 kg/m2) and weight (126 kg vs 145 kg) compared to the NC group (p < 0.05). The C group had significantly higher overall complication rate (10/26 vs 14/84, p < 0.05) and severity of complications (CD class ≥ III, 12% vs 7%, p < 0.05) when compared to the NC group. The length of stay was similar between the two groups (5 days vs 4 days). The C group had significant improvement in model end-stage liver disease scores (7 vs 6, p < 0.01) with median follow-up of 4.5 years (range 2–11 years). There were no long-term cirrhosis-related complications or mortality in our studied cohort (0/26).

Conclusion

Bariatric surgery in cirrhotic patients has a higher risk of immediate postoperative complications. Long-term cirrhosis-related complications or mortality was not increased in this small cohort. Preoperative identification of liver cirrhosis may be useful for risk stratification, optimisation and informed consent. Bariatric surgery in well-compensated cirrhotic patients may be used as an aid to improve long-term outcome.
Literature
1.
go back to reference Andersen T, Gluud C. Liver morphology in morbid obesity: a literature survey. Int J Obes. 1984;8(2):97–16.PubMed Andersen T, Gluud C. Liver morphology in morbid obesity: a literature survey. Int J Obes. 1984;8(2):97–16.PubMed
2.
go back to reference Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem. 2008;19(9):567–76.CrossRef Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem. 2008;19(9):567–76.CrossRef
3.
4.
go back to reference Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):370–9.CrossRef Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):370–9.CrossRef
5.
go back to reference Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103(2):71–83.CrossRef Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103(2):71–83.CrossRef
6.
go back to reference Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int. 2008;28(8):152–64.CrossRef Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int. 2008;28(8):152–64.CrossRef
7.
go back to reference Xia JL, Dai C, Michalopoulos GK, et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol. 2006;168(5):1500–12.CrossRef Xia JL, Dai C, Michalopoulos GK, et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol. 2006;168(5):1500–12.CrossRef
8.
go back to reference Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion. 1990;47(4):208–14.CrossRef Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion. 1990;47(4):208–14.CrossRef
9.
go back to reference Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.CrossRef Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.CrossRef
10.
go back to reference Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135(1):48–58.CrossRef Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135(1):48–58.CrossRef
11.
go back to reference Jan A, Narwaria M, Mahawar K, et al. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.CrossRef Jan A, Narwaria M, Mahawar K, et al. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.CrossRef
12.
go back to reference Shimizu H, Phuong V, Maia M, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9(1):1–6.CrossRef Shimizu H, Phuong V, Maia M, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9(1):1–6.CrossRef
13.
go back to reference Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(10):897–901.CrossRef Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(10):897–901.CrossRef
14.
go back to reference Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.CrossRef Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.CrossRef
15.
go back to reference Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRef
16.
go back to reference Vuppalanchi R, Chalasani N. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49(1):306–17.CrossRef Vuppalanchi R, Chalasani N. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49(1):306–17.CrossRef
17.
go back to reference Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49(4):608–12.CrossRef Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49(4):608–12.CrossRef
18.
go back to reference Adams LA, Lymp JFS, Sauver J, et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–21.CrossRef Adams LA, Lymp JFS, Sauver J, et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–21.CrossRef
19.
go back to reference Berzigotti A, Garcia-Tsao G, Bosch J, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54(2):555–61.CrossRef Berzigotti A, Garcia-Tsao G, Bosch J, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54(2):555–61.CrossRef
20.
go back to reference Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64.CrossRef Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64.CrossRef
21.
go back to reference Chen Y, Wang X, Wang J, et al. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48(14):2137–45.CrossRef Chen Y, Wang X, Wang J, et al. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48(14):2137–45.CrossRef
22.
go back to reference Clark JM. Weight loss as a treatment for non-alcoholic fatty liver disease. J Clin Gastroenterol. 2006;40(Suppl 1):S39–43.PubMed Clark JM. Weight loss as a treatment for non-alcoholic fatty liver disease. J Clin Gastroenterol. 2006;40(Suppl 1):S39–43.PubMed
23.
go back to reference Cave M, Deaciuc I, Mendez C, et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem. 2007;18(3):184–95.CrossRef Cave M, Deaciuc I, Mendez C, et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem. 2007;18(3):184–95.CrossRef
24.
go back to reference Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol. 2009;15(48):6017–22.CrossRef Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol. 2009;15(48):6017–22.CrossRef
25.
go back to reference Peck-Radosavljevic M, Angeli P, Cordoba J, et al. Managing complications in cirrhotic patients. United European Gastroenterol J. 2015;3(1):80–94.CrossRef Peck-Radosavljevic M, Angeli P, Cordoba J, et al. Managing complications in cirrhotic patients. United European Gastroenterol J. 2015;3(1):80–94.CrossRef
26.
go back to reference Gondal A. B. et al. Metabolic syndrome and short-term postoperative complications in bariatric surgery: the whole is not always greater than the sum of its parts. J Am Coll Surg. 2018;227(4):72–3.CrossRef Gondal A. B. et al. Metabolic syndrome and short-term postoperative complications in bariatric surgery: the whole is not always greater than the sum of its parts. J Am Coll Surg. 2018;227(4):72–3.CrossRef
27.
go back to reference Dallal RM, Mattar SG, Lord JL, et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg. 2004;14(1):47–53.CrossRef Dallal RM, Mattar SG, Lord JL, et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg. 2004;14(1):47–53.CrossRef
28.
go back to reference Rebibo L, Gerin O, Verhaeghe P, et al. Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: a case-matched study. Surg Obes Relat Dis. 2014;10(3):405–10.CrossRef Rebibo L, Gerin O, Verhaeghe P, et al. Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: a case-matched study. Surg Obes Relat Dis. 2014;10(3):405–10.CrossRef
29.
go back to reference Woodford RM, Burton PR, O’Brien PE, et al. Laparoscopic adjustable gastric banding in patients with unexpected cirrhosis: safety and outcomes. Obes Surg. 2015;25(10):1858–62.CrossRef Woodford RM, Burton PR, O’Brien PE, et al. Laparoscopic adjustable gastric banding in patients with unexpected cirrhosis: safety and outcomes. Obes Surg. 2015;25(10):1858–62.CrossRef
30.
go back to reference Van Steenbergen W, Lenchmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes. 1995;199(Suppl 3):S27–36. Van Steenbergen W, Lenchmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes. 1995;199(Suppl 3):S27–36.
31.
go back to reference Pinho S, Carvalho M, Soares M, et al. Obesity surgery mortality risk score: can we go beyond mortality prediction? J Anesth Clin Res. 2015;6(9):562. Pinho S, Carvalho M, Soares M, et al. Obesity surgery mortality risk score: can we go beyond mortality prediction? J Anesth Clin Res. 2015;6(9):562.
32.
go back to reference Santo MA, Riccioppo D, Pajecki D, et al. Preoperative weight loss in super-obese patients: study of the rate of weight loss and its effects on surgical morbidity. Clinics. 2014;69(12):828–34.CrossRef Santo MA, Riccioppo D, Pajecki D, et al. Preoperative weight loss in super-obese patients: study of the rate of weight loss and its effects on surgical morbidity. Clinics. 2014;69(12):828–34.CrossRef
33.
go back to reference Benotti P, Wood GC, Winegar DA, et al. Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg. 2014;259(1):123–30.CrossRef Benotti P, Wood GC, Winegar DA, et al. Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg. 2014;259(1):123–30.CrossRef
34.
go back to reference Pestana L, Swain J, Dierkhising R, et al. Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience. Mayo Clin Proc. 2015;90(2):209–15.CrossRef Pestana L, Swain J, Dierkhising R, et al. Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience. Mayo Clin Proc. 2015;90(2):209–15.CrossRef
35.
go back to reference Hanipah ZN, Punchai S, McCullough A, et al. Bariatric surgery in patients with cirrhosis and portal hypertension. Obes Surg. 2018;28(11):3431–8.CrossRef Hanipah ZN, Punchai S, McCullough A, et al. Bariatric surgery in patients with cirrhosis and portal hypertension. Obes Surg. 2018;28(11):3431–8.CrossRef
Metadata
Title
Bariatric Surgery in Cirrhotic Patients: Is It Safe?
Authors
Hafsa Younus
Amit Sharma
Rosa Miquel
Alberto Quaglia
Subba Rao Kanchustambam
Kirstin A Carswell
Ameet G. Patel
Publication date
01-04-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04214-7

Other articles of this Issue 4/2020

Obesity Surgery 4/2020 Go to the issue